18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease

Journal of Nuclear Medicine

Volumn 50, Issue 10, 2009, Pages 1611-1620

  Rominger, Axel ^a   Saam, Tobias ^b   Wolpers, Sarah ^a   Cyran, Clemens C ^b   Schmidt, Michael ^a   Foerster, Stefan ^a   Nikolaou, Konstantin ^b   Reiser, Maximilian F ^b   Bartenstein, Peter ^a   Hacker, Marcus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Atherosclerosis; Imaging; PET CT; Plaque; Risk factors

Indexed keywords

FLUORODEOXYGLUCOSE F 18; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SCOPOLAMINE BUTYL BROMIDE; DIAGNOSTIC AGENT;

ABDOMINAL AORTA; ADULT; AGED; AORTA ARCH; ARTERY CALCIFICATION; ARTICLE; ASCENDING AORTA; ATHEROSCLEROTIC PLAQUE; BLOOD; CANCER PATIENT; CANCER SURVIVAL; CARDIOVASCULAR RISK; CAROTID ARTERY; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DESCENDING AORTA; DRUG UPTAKE; FEMALE; FOLLOW UP; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; ILIAC ARTERY; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; PARAMETER; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REVASCULARIZATION; RISK FACTOR; STANDARDIZED VALUE UPTAKE; STATISTICAL ANALYSIS; WHOLE BODY IMAGING; ARTERY; ATHEROSCLEROSIS; CALCINOSIS; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; INCIDENTAL FINDING; INFLAMMATION; METABOLISM; MIDDLE AGED; NUCLEAR MEDICINE; RADIOGRAPHY; RADIOLOGY; RISK; SCINTISCANNING; SEXUAL DEVELOPMENT; SURVIVAL; VASCULAR DISEASE; VASCULARIZATION;

AGED; ARTERIES; ATHEROSCLEROSIS; CALCINOSIS; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; COHORT STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; INCIDENTAL FINDINGS; INFLAMMATION; MALE; MIDDLE AGED; NEOPLASMS; NUCLEAR MEDICINE; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOLOGY; RISK; SEX CHARACTERISTICS; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR DISEASES;

EID: 70349637021     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.065151     Document Type: Article

References (39)

1. Weintraub HS. Identifying the vulnerable patient with rupture-prone plaque. Am J Cardiol. 2008;101:3F-10F.
2. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics: 2008 update - a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25-e146.
3. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II. Circulation. 2003;108:1772-1778. (Pubitemid 37296082)
4. Izquierdo-Garcia D, Davies JR, Graves MJ, et al. Comparison of methods for magnetic resonance-guided [18-F]fluorodeoxyglucose positron emission tomography in human carotid arteries: reproducibility, partial volume correction, and correlation between methods. Stroke. 2009;40:18-93.
5. Rudd JH, Myers KS, Bansilal S, et al. (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol. 2007;50:892-896. (Pubitemid 47268746)
6. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695.
7. 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med. 2008;49:871-878.
8. Ogawa M, Ishino S, Mukai T, et al. 18F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J Nucl Med. 2004;45:1245-1250. (Pubitemid 47611672)
9. 18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;105:2708-2711.
10. 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke. 2005;36:2642-2647.
11. 18F- fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol. 2006;48:1818-1824.
12. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the unstable plaque. Prog Cardiovasc Dis. 2002;44:349-356.
13. Folsom AR, Kronmal RA, Detrano RC, et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med. 2008;168:1333-1339.
14. Eisen A, Tenenbaum A, Koren-Morag N, et al. Calcification of the thoracic aorta as detected by spiral computed tomography among stable angina pectoris patients: association with cardiovascular events and death. Circulation. 2008;118:1328-1334.
15. Rudd JHF, Myers KS, Bansilal S, et al. The relationships between regional arterial inflammation, calcification, risk factors and biomarkers: a prospective FDG PET/CT imaging study. Circ Cardiovasc Imaging. 2009;2:107-115.
16. Brown ER, Kronmal RA, Bluemke DA, et al. Coronary calcium coverage score: determination, correlates, and predictive accuracy in the Multi-Ethnic Study of Atherosclerosis. Radiology. 2008;247:669-675.
17. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310. (Pubitemid 16134762)
18. O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol. 2000;36:326-340. (Pubitemid 30466157)
19. Weber WA, Grosu AL, Czernin J. Technology insight: advances in molecular imaging and an appraisal of PET/CT scanning. Nat Clin Pract Oncol. 2008;5:160-170. (Pubitemid 351330668)
20. 18FDG PET: illusion or reality? A critical review of the literature data. Eur J Nucl Med Mol Imaging. 2003;30:1305-1313.
21. Di Carli MF, Dorbala S, Meserve J, El Fakhri G, Sitek A, Moore SC. Clinical myocardial perfusion PET/CT. J Nucl Med. 2007;48:783-793.
22. 18F-FDG PET/CT. J Nucl Med. 2004;45:1816-1821.
23. Bural GG, Torigian DA, Chamroonrat W, et al. FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging. 2008;35:562-569. (Pubitemid 351674338)
24. Paulmier B, Duet M, Khayat R, et al. Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events. J Nucl Cardiol. 2008;15:209-217.
25. Yun M, Jang S, Cucchiara A, Newberg AB, Alavi A. 18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. Semin Nucl Med. 2002;32:70-76. (Pubitemid 34112944)
26. Yun M, Yeh D, Araujo LI, Jang S, Newberg A, Alavi A. F-18 FDG uptake in the large arteries: a new observation. Clin Nucl Med. 2001;26:314-319. (Pubitemid 32226294)
27. 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques. J Nucl Med. 2006;47:1845-1850.
28. Tahara N, Kai H, Ishibashi M, et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol. 2006;48:1825-1831. (Pubitemid 44648621)
29. Abbott RD, Ueshima H, Masaki KH, et al. Coronary artery calcification and total mortality in elderly men. J Am Geriatr Soc. 2007;55:1948-1954. (Pubitemid 350230960)
30. Budoff MJ, Shaw LJ, Liu ST, et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol. 2007;49:1860-1870.
31. Ben-Haim S, Israel O. PET/CT for atherosclerotic plaque imaging. Q J Nucl Med Mol Imaging. 2006;50:53-60.
32. 18F-FDG uptake with vascular calcification. J Nucl Med. 2005;46:1278-1284.
33. Tatsumi M, Cohade C, Nakamoto Y, Wahl RL. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis. Radiology. 2003;229:831-837. (Pubitemid 37467590)
34. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874.
35. Detrano RC, Wong ND, Doherty TM, et al. Coronary calcium does not accurately predict near-term future coronary events in high-risk adults. Circulation. 1999;99:2633-2638.
36. Schmermund A, Erbel R. Unstable coronary plaque and its relation to coronary calcium. Circulation. 2001;104:1682-1687. (Pubitemid 32947534)
37. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area: a histopathologic correlative study. Circulation. 1995;92:2157-2162.
38. Shaw LJ, Raggi P, Schisterman E, Berman DS, Callister TQ. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology. 2003;228:826-833. (Pubitemid 37025495)
39. 18F-FDG PET/CT examinations. J Nucl Med. 2005;46:608-613.